Providence Therapeutics is a clinical-stage mRNA platform company developing vaccines for cancers and infectious diseases. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. We are building a portfolio of oncology vaccines while advancing a coronavirus vaccine candidate. Additionally, we’re pursuing vaccine programs for infectious diseases that pose public health risks, including influenza and rabies. For more information, please visit providencetherapeutics.com.